In vivo neuroprotective effects of peripheral kynurenine on acute neurotoxicity induced by glutamate in rat cerebral cortex

Neurochemical Research

Volumn 35, Issue 4, 2010, Pages 636-644

  Kumar, Alok ^a   Nagesh Babu, G ^a  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Antioxidant enzymes; KYNA NMDA receptors; Mitochondrial dysfunction; Neuroinflammation; Tryptophan

Indexed keywords

CALCIUM; CATALASE; GAMMA INTERFERON; GLUTAMIC ACID; GLUTATHIONE; GLUTATHIONE REDUCTASE; KYNURENIC ACID; KYNURENINE; NITRIC OXIDE; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; ASTROCYTE; BRAIN CORTEX; CONTROLLED STUDY; DRUG PENETRATION; IN VIVO STUDY; LIPID PEROXIDATION; MALE; MITOCHONDRIAL MEMBRANE POTENTIAL; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PRIMARY PREVENTION; PRIORITY JOURNAL; RAT;

ANIMALS; CATALASE; CEREBRAL CORTEX; FLOW CYTOMETRY; GLUTAMIC ACID; GLUTATHIONE; GLUTATHIONE REDUCTASE; KYNURENINE; LIPID PEROXIDATION; MALE; NEUROPROTECTIVE AGENTS; RATS; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES; SUPEROXIDE DISMUTASE;

RATTUS;

EID: 77953543635     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11064-009-0114-6     Document Type: Article

References (25)

1. Erhardt S, Olsson SK, Engberg G (2009) Pharmacological manipulation of kynurenic acid: potential in the treatment of psychiatric disorders. CNS Drugs 23:91-101
2. Poeggeler B, Rassoulpour A, Wu HQ et al (2007) Dopamine receptor activation reveals a novel, kynurenate-sensitive component of striatal N-methyl-D-aspartate neurotoxicity. Neuroscience 148:188-197
3. Swartz KJ, During MJ, Freese A et al (1990) Cerebral synthesis and release on kynurenic acid and endogenous antagonist of excitatory amino acid receptors. J Neurosci 10:2965-2973
4. Fukui S, Schwartz R, Rapoport SI et al (1991) Blood-brain barrier transport of kynurenines: implications for brain synthesis and metabolism. J Neurochem 56:2007-2017
5. Robotka H, Sas K, Agoston M et al (2008) Neuroprotection achieved in the ischaemic rat cortex with L-kynurenine sulphate. Life Sci 23:915-919
6. Stone TW, Darlington LG (2002) Endogenous kynurenines as targets for drug discovery and development. Nat Rev Drug Discov 1:609-620
7. Bawari M, Babu GN (2003) Metabolic responses in discrete regions of rat brain following acute administration of glutamate. Neurochem Res 28:1345-1349
8. Santamaria A, Rios C, Solis-Hernandez F et al (1996) Systemic DL-kynurenine and probenecid pretreatment attenuates quinolinic acid-induced neurotoxicity in rats. Neuropharmacology 35: 23-28
9. Utley HG, Bernheim F, Hochstein P (1967) Effect of sulfhydryl reagent on peroxidation in microsome. Arch Biochem Biophys 118:29-32
10. Nishikimi M, Appaji Rao N, Yagi K (1972) The occurrence of superoxide anion in the reaction of reduced phenazine methosulfate and molecular oxygen. Biochem Biophys Res Commun 46:849-854
11. Aebi H (1984) Catalase in vitro. Methods Enzymol 105:121-126
12. Brehe JE, Burch HB (1976) Enzymatic assay for glutathione. Anal Biochem 74:189-197
13. Racker E (1955) Glutathione reductase from bakers' yeast and beef liver. J Biol Chem 217:855-865
14. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254
15. Green LC, Wagner DA, Glogowski J et al (1982) Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. Anal Biochem 126:131-138
16. Rastogi L, Godbole MM, Ray M, Rathore P et al (2006) Reduction in oxidative stress and cell death explains hypothyroidism induced neuroprotection subsequent to ischemia/reperfusion insult. Exp Neurol 200:290-300
17. Rathore P, Dohare P, Varma S et al (2008) Curcuma oil: reduces early accumulation of oxidative product and is antiapoptogenic in transient focal ischemia in rat brain. Neurochem Res 33:1672-1682
18. Emaus RK, Grunwald R, Lemasters JJ (1986) Rhodamine 123 is a probe of transmembrane potential in isolated rat liver mitochondria: spectral and metabolic properties. Biochim Biophys Acta 850:436-448
19. Babu GN, Kumar A, Chandra R et al (2008) Elevated inflammatory markers in a group of amyotrophic lateral sclerosis patients from northern India. Neurochem Res 33:1145-1149
20. Vamos E, Pardutz A, Varga H et al (2009) l-kynurenine combined with probenecid and the novel synthetic kynurenic acid derivative attenuate nitroglycerin-induced nNOS in the rat caudal trigeminal nucleus. Neuropharmacology 57:425-429
21. Leipnitz G, Schumacher C, Dalcin KB et al (2007) In vitro evidence for an antioxidant role of 3-hydroxykynurenine and 3-hydroxyanthranilic acid in the brain. Neurochem Int 50:83-94
22. Prescott C, Weeks AM, Staley KJ, Partin KM (2006) Kynurenic acid has a dual action on AMPA receptor responses. Neurosci Lett 402:108-112
23. Swartz KJ, During MJ, Freese A et al (1990) Cerebral synthesis and release of kynurenic acid: antagonist of excitatory amino acid receptors. J Neuosci 10:2965-2973
24. Wu HQ, Pereira EF, Bruno JP et al (2009) The astrocyte-serived alpha7 nicotinic receptor antagonist kynurenic acid controls extracellular glutamate levels in the prefrontal cortex. J Mol Neurosci. doi: 10.1007/s12031-009-9235-2
25. Vamos E, Pardutz A, Klivenyi P et al (2009) The role of kynurenines in disorders of the central nervous system: possibilities for neuroprotection. J Neurol Sci 283:21-27